These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22787010)

  • 41. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac resynchronization therapy reduces T-wave alternans in patients with heart failure.
    Hua W; Chen K; Zhou X; Dai Y; Chen R; Wang J; Ding L; Liu Z; Feng T; Yu J; Cheng J; Liu C; Zhang S
    Europace; 2015 Feb; 17(2):281-8. PubMed ID: 25398405
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apical rocking is predictive of response to cardiac resynchronization therapy.
    Ghani A; Delnoy PP; Ottervanger JP; Misier AR; Smit JJ; Adiyaman A; Elvan A
    Int J Cardiovasc Imaging; 2015 Apr; 31(4):717-25. PubMed ID: 25651877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy.
    Solomon SD; Foster E; Bourgoun M; Shah A; Viloria E; Brown MW; Hall WJ; Pfeffer MA; Moss AJ;
    Circulation; 2010 Sep; 122(10):985-92. PubMed ID: 20733097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy.
    Alpendurada F; Guha K; Sharma R; Ismail TF; Clifford A; Banya W; Mohiaddin RH; Pennell DJ; Cowie MR; McDonagh T; Prasad SK
    J Cardiovasc Magn Reson; 2011 Oct; 13(1):68. PubMed ID: 22040270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
    Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
    Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PR interval identifies clinical response in patients with non-left bundle branch block: a Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy substudy.
    Kutyifa V; Stockburger M; Daubert JP; Holmqvist F; Olshansky B; Schuger C; Klein H; Goldenberg I; Brenyo A; McNitt S; Merkely B; Zareba W; Moss AJ
    Circ Arrhythm Electrophysiol; 2014 Aug; 7(4):645-51. PubMed ID: 24963007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between frequency of atrial and ventricular ectopic beats and biventricular pacing percentage and outcomes in patients with cardiac resynchronization therapy.
    Ruwald MH; Mittal S; Ruwald AC; Aktas MK; Daubert JP; McNitt S; Al-Ahmad A; Jons C; Kutyifa V; Steinberg JS; Wang P; Moss AJ; Zareba W
    J Am Coll Cardiol; 2014 Sep; 64(10):971-81. PubMed ID: 25190230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Additive Prognostic Value of Echocardiographic Global Longitudinal and Global Circumferential Strain to Electrocardiographic Criteria in Patients With Heart Failure Undergoing Cardiac Resynchronization Therapy.
    Delgado-Montero A; Tayal B; Goda A; Ryo K; Marek JJ; Sugahara M; Qi Z; Althouse AD; Saba S; Schwartzman D; Gorcsan J
    Circ Cardiovasc Imaging; 2016 Jun; 9(6):. PubMed ID: 27252359
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Characteristics and Outcomes of Older Cardiac Resynchronization Therapy Recipients Using a Pacemaker versus a Defibrillator.
    Munir MB; Althouse AD; Rijal S; Shah MB; Abu Daya H; Adelstein E; Saba S
    J Cardiovasc Electrophysiol; 2016 Jun; 27(6):730-4. PubMed ID: 26856440
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complications in recipients of cardioverter-defibrillator or cardiac resynchronization therapy: Insights from Silesian Center Defibrillator registry.
    Tajstra M; Gadula-Gacek E; Kurek A; Adamowicz-Czoch E; Olszowski D; Ostręga M; Ciślak A; Pyka Ł; Hawranek M; Lekston A; Poloński L; Gąsior M
    Cardiol J; 2017; 24(5):515-522. PubMed ID: 27734455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic Role of Right Ventricular Function in Patients With Heart Failure Undergoing Cardiac Resynchronization Therapy.
    Rapacciuolo A; Maffè S; Palmisano P; Ferraro A; Cecchetto A; D'Onofrio A; Solimene F; Musatti P; Paffoni P; Esposito F; Parravicini U; Agresta A; Botto GL; Malacrida M; Stabile G
    Clin Cardiol; 2016 Nov; 39(11):640-645. PubMed ID: 27468173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systolic Blood Pressure and Risk for Ventricular Arrhythmia in Patients With an Implantable Cardioverter Defibrillator.
    Beinart R; Goldenberg I; Younis A; McNitt S; Huang D; Aktas MK; Spencer R; Kutyifa V; Nof E
    Am J Cardiol; 2021 Mar; 143():74-79. PubMed ID: 33359194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiarrhythmic effect of cardiac resynchronization therapy with triple-site biventricular stimulation.
    Ogano M; Iwasaki YK; Tanabe J; Takagi H; Umemoto T; Hayashi M; Miyauchi Y; Mizuno K
    Europace; 2013 Oct; 15(10):1491-8. PubMed ID: 23696627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older.
    Adelstein EC; Liu J; Jain S; Schwartzman D; Althouse AD; Wang NC; Gorcsan J; Saba S
    Europace; 2016 Mar; 18(3):420-7. PubMed ID: 26487669
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arrhythmic Risk in Biventricular Pacing Compared With Left Bundle Branch Area Pacing: Results From the I-CLAS Study.
    Herweg B; Sharma PS; Cano Ó; Ponnusamy SS; Zanon F; Jastrzebski M; Zou J; Chelu MG; Vernooy K; Whinnett ZI; Nair GM; Molina-Lerma M; Curila K; Zalavadia D; Dye C; Vipparthy SC; Brunetti R; Mumtaz M; Moskal P; Leong AM; van Stipdonk A; George J; Qadeer YK; Kolominsky J; Golian M; Morcos R; Marcantoni L; Subzposh FA; Ellenbogen KA; Vijayaraman P
    Circulation; 2024 Jan; 149(5):379-390. PubMed ID: 37950738
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT).
    Healey JS; Hohnloser SH; Exner DV; Birnie DH; Parkash R; Connolly SJ; Krahn AD; Simpson CS; Thibault B; Basta M; Philippon F; Dorian P; Nair GM; Sivakumaran S; Yetisir E; Wells GA; Tang AS;
    Circ Heart Fail; 2012 Sep; 5(5):566-70. PubMed ID: 22896584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanical dyssynchrony after cardiac resynchronization therapy for severely symptomatic heart failure is associated with risk for ventricular arrhythmias.
    Haugaa KH; Marek JJ; Ahmed M; Ryo K; Adelstein EC; Schwartzman D; Saba S; Gorcsan J
    J Am Soc Echocardiogr; 2014 Aug; 27(8):872-9. PubMed ID: 24798865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Digoxin therapy and associated clinical outcomes in the MADIT-CRT trial.
    Lee AY; Kutyifa V; Ruwald MH; McNitt S; Polonsky B; Zareba W; Moss AJ; Ruwald AC
    Heart Rhythm; 2015 Sep; 12(9):2010-7. PubMed ID: 26025322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.